Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 0.94 INR
Change Today +0.03 / 3.30%
Volume 5.1K
ZHC On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:26 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

zenith health care ltd (ZHC) Snapshot

Open
0.95
Previous Close
0.91
Day High
0.95
Day Low
0.92
52 Week High
09/24/14 - 1.33
52 Week Low
02/2/15 - 0.57
Market Cap
50.5M
Average Volume 10 Days
6.7K
EPS TTM
-0.08
Shares Outstanding
53.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZENITH HEALTH CARE LTD (ZHC)

Related News

No related news articles were found.

zenith health care ltd (ZHC) Related Businessweek News

No Related Businessweek News Found

zenith health care ltd (ZHC) Details

Zenith Healthcare Limited manufactures, sells, and exports pharmaceutical formulations in India. The company offers its products in the forms of tablets, capsules, oral liquids, and injectables. It focuses on developing therapeutic products in the areas of antibiotics and anti-infectives, gastrointestinal, analgesic/anti-inflammatory, cardiovascular, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system, and skin. The company also provides contract manufacturing of various dosage forms. Zenith Healthcare Limited was incorporated in 1994 and is based in Ahmedabad, India.

Founded in 1994

zenith health care ltd (ZHC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zenith health care ltd (ZHC) Key Developments

Zenith Healthcare Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Zenith Healthcare Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported net sales of INR 11.780 million against INR 8.320 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 0.814 million against INR 1.665 million for the same period of last year. Loss from ordinary activities before tax was INR 0.750 million against INR 1.447 million for the same period of last year. Net loss for the period was INR 0.750 million against INR 1.447 million for the same period of last year. For the nine months, the company reported loss from operations before other income, finance costs and exceptional items of INR 2.076 million against INR 2.867 million for the same period of last year. Loss from ordinary activities before tax was INR 1.857 million against INR 2.342 million for the same period of last year. Net loss for the period was INR 1.857 million against INR 2.342 million for the same period of last year. Net sales/income from operations was INR 38.991 million against INR 25.761 million for the same period of last year.

Zenith Healthcare Ltd, Board Meeting, Feb 10, 2015

Zenith Healthcare Ltd, Board Meeting, Feb 10, 2015. Agenda: To consider unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014.

Zenith Healthcare Ltd Announces Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2014

Zenith Healthcare Ltd. announced unaudited standalone earnings results for the second quarter and half year ended September 30, 2014. For the quarter, the company reported net sales/income from operations of INR 8.152 million compared to INR 8.513 million a year ago. Total income for operations was INR 8.262 million compared to INR 8.538 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 0.495 million compared to INR 1.215 million a year ago. Loss from ordinary activities before tax was INR 0.410 million compared to INR 1.048 million a year ago. Net loss for the period was INR 0.410 million compared to INR 1.048 million a year ago. For the half year, the company reported net sales/income from operations of INR 17.211 million compared to INR 17.441 million a year ago. Total income for operations was INR 17.379 million compared to INR 17.543 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 1.262 million compared to INR 1.202 million a year ago. Loss from ordinary activities before tax was INR 1.107 million compared to INR 0.895 million a year ago. Net loss for the period was INR 1.107 million compared to INR 0.895 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZHC:IN 0.94 INR +0.03

ZHC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ZHC.
View Industry Companies
 

Industry Analysis

ZHC

Industry Average

Valuation ZHC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 81.4x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZENITH HEALTH CARE LTD, please visit www.zenithhealthcare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.